ARCHIVES

Arimidex Reduces Relapse Compared To Tamoxifen, Large Study Reports

This article is from The Cancer Letter archive.

Vol. 24 No. 12 | December 28, 2001

Download PDF Visit The Full Archive

Related Articles

In Brief: Megastrol Acetate Still Under FDA Review; Mays Hired For NCI’s Technology Office

July 20, 1990

In the Cancer Centers: Rosen Moves To City Of Hope

November 1, 2013

Evidence Lacking On Value of Vitamins to Prevent Disease, Panel Says.

June 16, 2006

NCI Intramural Budget And List Of Highest-Funded Branches, Laboratories

April 21, 1995

In Sign-Off Of Two Orphan Drugs, ODAC Leaves Efficacy Interpretation To Docs

November 27, 1998

Varmus’s 2016 Bypass Budget Seeks “Modest” Increase of $823 Million

December 5, 2014